160 related articles for article (PubMed ID: 33365314)
21. TMEM200A is a potential prognostic biomarker and correlated with immune infiltrates in gastric cancer.
Fang F; Zhang T; Lei H; Shen X
PeerJ; 2023; 11():e15613. PubMed ID: 37404478
[TBL] [Abstract][Full Text] [Related]
22. Elevated expression of mitochondrial transcription elongation factor (TEFM) predicts poor prognosis in low grade glioma-an analysis of the Cancer Genome Atlas (TCGA) dataset.
Li S; Wang W; Zi J; Sun M; Mei W; Yang N; Zhang R; Yu M; Xiong W
Transl Cancer Res; 2020 May; 9(5):3610-3622. PubMed ID: 35117724
[TBL] [Abstract][Full Text] [Related]
23. Trim47 overexpression correlates with poor prognosis in gastric cancer.
Xia Y; Wei Z; Huang W; Wei X; He Y
Neoplasma; 2021 Mar; 68(2):307-316. PubMed ID: 33350849
[TBL] [Abstract][Full Text] [Related]
24. Identification of an EMT-Related Gene Signature for Predicting Overall Survival in Gastric Cancer.
Dai W; Xiao Y; Tang W; Li J; Hong L; Zhang J; Pei M; Lin J; Liu S; Wu X; Xiang L; Wang J
Front Genet; 2021; 12():661306. PubMed ID: 34249086
[TBL] [Abstract][Full Text] [Related]
25. N6-methyladenosine-related lncRNAs identified as potential biomarkers for predicting the overall survival of Asian gastric cancer patients.
Xu S; Chen W; Wang Y; Zhang Y; Xia R; Shen J; Gong X; Liang Y; Xu J; Tang H; Zhao T; Zhang Y; Chen T; Wang C
BMC Cancer; 2022 Jul; 22(1):721. PubMed ID: 35778697
[TBL] [Abstract][Full Text] [Related]
26. Identified a disintegrin and metalloproteinase with thrombospondin motifs 6 serve as a novel gastric cancer prognostic biomarker by bioinformatics analysis.
Zhu YZ; Liu Y; Liao XW; Luo SS
Biosci Rep; 2021 Apr; 41(4):. PubMed ID: 33851708
[TBL] [Abstract][Full Text] [Related]
27. Diagnostic and prognostic value of MATN3 expression in gastric carcinoma: TCGA database mining.
Li D; Xu J; Dong X; Chen W; Pan L; Jiang H; Pan J; Huang Y
J Gastrointest Oncol; 2021 Aug; 12(4):1374-1383. PubMed ID: 34532095
[TBL] [Abstract][Full Text] [Related]
28. HIPPO signaling-related signature for predicting prognosis and therapeutic response in gastric cancer.
Jiang R; Wang J; Liang J; Lin D; Mao Q; Cheng S; Huang S; Tong S; Lyu Y; Wei R; Lian Q; Chen H
Front Pharmacol; 2022; 13():1096055. PubMed ID: 36712672
[No Abstract] [Full Text] [Related]
29. Expression Status And Prognostic Value Of M6A-associated Genes in Gastric Cancer.
Guan K; Liu X; Li J; Ding Y; Li J; Cui G; Cui X; Sun R
J Cancer; 2020; 11(10):3027-3040. PubMed ID: 32226518
[No Abstract] [Full Text] [Related]
30. Cyclin-Dependent Kinase 1 (CDK1) is Co-Expressed with CDCA5: Their Functions in Gastric Cancer Cell Line MGC-803.
Huang Z; Zhang S; Du J; Zhang X; Zhang W; Huang Z; Ouyang P
Med Sci Monit; 2020 Aug; 26():e923664. PubMed ID: 32759885
[TBL] [Abstract][Full Text] [Related]
31. THBS2 is Closely Related to the Poor Prognosis and Immune Cell Infiltration of Gastric Cancer.
Zhang S; Yang H; Xiang X; Liu L; Huang H; Tang G
Front Genet; 2022; 13():803460. PubMed ID: 35186032
[No Abstract] [Full Text] [Related]
32. Comprehensive Analysis of the Expression and Prognosis for ITGBs: Identification of ITGB5 as a Biomarker of Poor Prognosis and Correlated with Immune Infiltrates in Gastric Cancer.
Liu D; Liu S; Fang Y; Liu L; Hu K
Front Cell Dev Biol; 2021; 9():816230. PubMed ID: 35223869
[No Abstract] [Full Text] [Related]
33. BGN May be a Potential Prognostic Biomarker and Associated With Immune Cell Enrichment of Gastric Cancer.
Zhang S; Yang H; Xiang X; Liu L; Huang H; Tang G
Front Genet; 2022; 13():765569. PubMed ID: 35154268
[No Abstract] [Full Text] [Related]
34. Downregulation of PSCA promotes gastric cancer proliferation and is related to poor prognosis.
Xu LP; Qiu HB; Yuan SQ; Chen YM; Zhou ZW; Chen YB
J Cancer; 2020; 11(9):2708-2715. PubMed ID: 32201541
[No Abstract] [Full Text] [Related]
35. The Role of SETBP1 in Gastric Cancer: Friend or Foe.
Fang F; Liu C; Li Q; Xu R; Zhang T; Shen X
Front Oncol; 2022; 12():908943. PubMed ID: 35898891
[TBL] [Abstract][Full Text] [Related]
36. Increased IGFBP7 Expression Correlates with Poor Prognosis and Immune Infiltration in Gastric Cancer.
Zhao Q; Zhao R; Song C; Wang H; Rong J; Wang F; Yan L; Song Y; Xie Y
J Cancer; 2021; 12(5):1343-1355. PubMed ID: 33531979
[No Abstract] [Full Text] [Related]
37. Identification of a Four-Gene-Based SERM Signature for Prognostic and Drug Sensitivity Prediction in Gastric Cancer.
Jia X; Chen B; Li Z; Huang S; Chen S; Zhou R; Feng W; Zhu H; Zhu X
Front Oncol; 2021; 11():799223. PubMed ID: 35096599
[TBL] [Abstract][Full Text] [Related]
38. Role of CXCR4 as a Prognostic Biomarker Associated With the Tumor Immune Microenvironment in Gastric Cancer.
Gu Y; Gu W; Xie R; Chen Z; Xu T; Fei Z
Front Cell Dev Biol; 2021; 9():654504. PubMed ID: 34568309
[No Abstract] [Full Text] [Related]
39. Flap endonuclease 1 (FEN1) as a novel diagnostic and prognostic biomarker for gastric cancer.
Zhao E; Zhou C; Chen S
Clin Res Hepatol Gastroenterol; 2021 Jan; 45(1):101455. PubMed ID: 32505732
[TBL] [Abstract][Full Text] [Related]
40. High expression of oncogene cadherin-6 correlates with tumor progression and a poor prognosis in gastric cancer.
Zhao Z; Li S; Li S; Wang J; Lin H; Fu W
Cancer Cell Int; 2021 Sep; 21(1):493. PubMed ID: 34530820
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]